Current Challenge
| |
Chances of surviving cancer improve dramatically when it is detected at an early stage.
|
Early detection is the key to successful treatment. There is significant need for the tests being developed by Onconome because current detection methods, to the extent they exist at all, are non-specific and insensitive.
Prostate Specific Antigen (PSA) is a prominent example. The PSA test results in 80% false positive readings and 20% false negative readings, meaning that a vast majority of men with elevated PSA levels actually do not have prostate cancer and, conversely, 20% of men with presumably "normal" PSA levels actually do have prostate cancer. Nevertheless, decisions regarding additional diagnostic tests are made today based upon PSA results, resulting in often unneeded and uncomfortable biopsies.
We are working hard towards providing proprietary tests that will effectively address the huge unmet need for early and accurate detection of cancer as well as other major diseases where early diagnosis can have profound effects on quality of life and disease free survival.
|
